Erratum

After the publication of the Drug Profile by Jasper J Brugts, Roberto Ferrari and Maarten L Simoons, Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease, published in the April 2009 issue of Expert Review of Cardiovascular Therapy (Expert Rev. Cardiovasc. Ther. 7[4], 345–360 [2009]) it has been brought to our attention that Figure 3 was drawn incorrectly as follows:

Figure 3. Tissue potency of different angiotensin-converting enzyme inhibitors.

Modified with permission from [36].

The correct Figure 3 is given below:

Figure 3. Tissue potency of different angiotensin-converting enzyme inhibitors.

Modified with permission from [36].

The editors of Expert Review of Cardiovascular Therapy and the authors would like to sincerely apologize for any inconvenience or confusion this may have caused the readers.